Literature DB >> 28769310

SENSITIZATION STATE OF POTENTIAL LIVE RELATED DONOR RENAL TRANSPLANT PATIENTS.

G S Chopra1, A S Narula2, N K Mehra3.   

Abstract

Sensitization state of 119 patients of end-stage renal disease registered for live related donor transplant was assessed by determining the panel reactive antibody (PRA) status and the donor-specific crossmatch positivity. Eighty one patients (69.1%) showed no PRA, whereas 27 (22.6%) had PRA less than 10% and the remaining 11 patients (9.2%) displayed PRA more than 10%. The lower level of sensitization was related to the short dialysis period, less number of blood transfusions, fewer female patiente, and lesser number of retransplants. Cross-match positive patients were in the higher PRA group (range 32-68%) as compared to 0-24% PRA in cross-match negative group.

Entities:  

Keywords:  Cytotoxicity tests; Histocompatibility testing; Kidney transplantation; Transplantation immunology

Year:  2017        PMID： 28769310      PMCID： PMC5530212          DOI： 10.1016/S0377-1237(17)30988-7

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


  12 in total

1.  Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.

Authors:  L Roels; Y Vanrenterghem; M Waer; J Dendievel; M P Emonds; R Christiaens; J Gruwez; P Michielsen
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.

Authors:  L Mjörnstedt; J Konar; I Skarp; M Olausson; L Sandberg; G Tufvesson
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

3.  Lymphocytotoxic antibodies in 1500 potential first kidney transplant recipients.

Authors:  S R Lieber; M Gerbase-DeLima; L B Persoli; F Pedro-Filho; J H Setta; W Montagna; J O Pestana
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

4.  Influence of race, PRA level, and gender on the incidence of a positive donor-specific preliminary T cell crossmatch.

Authors:  C F Bryan; M I Aeder; T S Helling; A M Luger; P W Nelson; G E Pierce; C F Shield; A Thomas
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

5.  Hyperreactivity against panel: a risk factor for renal transplant.

Authors:  F J Paula; N Panajotopoulos; H Rodrigues; J E Kalil; E Sabbaga; S Arap
Journal:  Transplant Proc       Date:  1992-10       Impact factor: 1.066

6.  Renal transplantation in patients with lymphocytotoxic antibodies--a 5-year experience from a single centre.

Authors:  L Mjörnstedt; J Konar; G Nyberg; M Olausson; L Sandberg; I Karlberg
Journal:  Transplant Proc       Date:  1992-02       Impact factor: 1.066

7.  Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination.

Authors:  M J Kreisler; A A Hirata; P I Terasaki
Journal:  Transplantation       Date:  1970-11       Impact factor: 4.939

Review 8.  Council of Europe study of high sensitization in renal transplantation.

Authors:  B A Bradley; S M Gore
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

9.  The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation.

Authors:  J D Smith; A J Danskine; R M Laylor; M L Rose; M H Yacoub
Journal:  Transpl Immunol       Date:  1993       Impact factor: 1.708

10.  Occurrence of lymphocytotoxins in multi-case rheumatoid arthritis families: relation to HLA.

Authors:  V Taneja; N K Mehra; R R Singh; C Anand; A N Malaviya
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.